LP002 is the Bridge Study and should be complete this month. They did say they might add patients in order to power certain data sets. Not sure how that influences the timeline but I expect later in Sept. This study will confirm results for V2 and should give a JV partner all they need to partner up. However, a JV partner may want CLIA validation, or the APP, complete before they partner. That effort was started on or around Sept 2nd when they announced the ICON labs agreement, likely give or take a week or so. I don't know what the August 10th reference is in your message? I am going by the announcement date of Sept 2nd plus 11-12 weeks.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links